HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells

被引:0
|
作者
M-L Gougeon
M-T Melki
H Saïdi
机构
[1] Antiviral Immunity,Infection and Epidemiology Department
[2] Biotherapy and Vaccine Unit,undefined
[3] Institut Pasteur,undefined
来源
Cell Death & Differentiation | 2012年 / 19卷
关键词
dendritic cell; HIV; HMGB1; natural killer cell; TRAIL;
D O I
暂无
中图分类号
学科分类号
摘要
Dendritic cells (DCs) initiate immune responses by transporting antigens and migrating to lymphoid tissues to initiate T-cell responses. DCs are located in the mucosal surfaces that are involved in human immunodeficiency virus (HIV) transmission and they are probably among the earliest targets of HIV-1 infection. DCs have an important role in viral transmission and dissemination, and HIV-1 has evolved different strategies to evade DC antiviral activity. High mobility group box 1 (HMGB1) is a DNA-binding nuclear protein that can act as an alarmin, a danger signal to alert the innate immune system for the initiation of host defense. It is the prototypic damage-associated molecular pattern molecule, and it can be secreted by innate cells, including DCs and natural killer (NK) cells. The fate of DCs is dependent on a cognate interaction with NK cells, which involves HMGB1 expressed at NK–DC synapse. HMGB1 is essential for DC maturation, migration to lymphoid tissues and functional type-1 polarization of naïve T cells. This review highlights the latest advances in our understanding of the impact of HIV on the interactions between HMGB1 and DCs, focusing on the mechanisms of HMGB1-dependent viral dissemination and persistence in DCs, and discussing the consequences on antiviral innate immunity, immune activation and HIV pathogenesis.
引用
收藏
页码:96 / 106
页数:10
相关论文
共 50 条
  • [41] Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients
    Stebbing, J
    Patterson, S
    Portsmouth, S
    Thomas, C
    Glassman, R
    Wildfire, A
    Gotch, F
    Bower, M
    Nelson, M
    Gazzard, B
    CELL RESEARCH, 2004, 14 (03) : 251 - 256
  • [42] Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVAHIV
    Cummings, Jean-Saville
    Moreno-Nieves, Uriel Y.
    Arnold, Vincent
    Gilbert, Adrien
    Yarbrough, Kevin
    Didier, Celine
    Levy, Yves
    Barre-Sinoussi, Francoise
    Scott-Algara, Daniel
    VACCINE, 2014, 32 (43) : 5577 - 5584
  • [43] Massive endocytosis mechanisms are involved in uptake of HIV-1 particles by monocyte-derived dendritic cells
    Laguia, Fernando
    Chojnacki, Jakub
    Erkizia, Itziar
    Geli, Maria Isabel
    Enrich, Carlos
    Martinez-Picado, Javier
    Resa-Infante, Patricia
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [44] Subpopulations of peripheral blood dendritic cells show differential susceptibility to infection with a lymphotropic strain of HIV-1
    Patterson, S
    Robinson, SP
    English, NR
    Knight, SC
    IMMUNOLOGY LETTERS, 1999, 66 (1-3) : 111 - 116
  • [45] Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes
    Garcia-Bates, Tatiana M.
    Palma, Mariana L.
    Anderko, Renee R.
    Hsu, Denise C.
    Ananworanich, Jintanat
    Korber, Bette T.
    Gaiha, Gaurav D.
    Phanuphak, Nittaya
    Thomas, Rasmi
    Tovanabutra, Sodsai
    Walker, Bruce D.
    Mellors, John W.
    Piazza, Paolo A.
    Kroon, Eugene
    Riddler, Sharon A.
    Michael, Nelson L.
    Rinaldo, Charles R.
    Mailliard, Robbie B.
    EBIOMEDICINE, 2021, 63
  • [46] Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1
    Sabado, Rachel L.
    Babcock, Ethan
    Kavanagh, Daniel G.
    Tjomsland, Veronica
    Walker, Bruce D.
    Lifson, Jeffrey D.
    Bhardwaj, Nina
    Larsson, Marie
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (07) : 1752 - 1763
  • [47] Mucosal dendritic cells in HIV-1 susceptibility: a critical role for C-type lectin receptors
    Hertoghs, Nina
    van Pul, Lisa
    Geijtenbeek, Teunis B. H.
    FUTURE VIROLOGY, 2017, 12 (07) : 373 - 388
  • [48] Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients
    Justin STEBBING
    Steve PATTERSON
    Simon PORTSMOUTH
    Claire THOMAS
    Robert GLASSMAN
    Adrian WILDFIRE
    Frances GOTCH
    Mark BOWER
    Mark NELSON
    Brian GAZZARD
    CellResearch, 2004, (03) : 251 - 256
  • [49] Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
    Routy, Jean-Pierre
    Boulassel, Mohamed-Rachid
    Yassine-Diab, Bader
    Nicolette, Charles
    Healey, Don
    Jain, Renu
    Landry, Claire
    Yegorov, Oleg
    Tcherepanova, Irina
    Monesmith, Tamara
    Finke, Lothar
    Sekaly, Rafick-Pierre
    CLINICAL IMMUNOLOGY, 2010, 134 (02) : 140 - 147
  • [50] Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
    Y Levy
    R Thiébaut
    M Montes
    C Lacabaratz
    L Sloan
    S Perusat
    C Harrod
    C Boucherie
    S Zurawski
    L Richert
    G Chêne
    J Banchereau
    K Palucka
    Retrovirology, 9